S. Schryber

发表

High-dose thiotepa alone and in combination regimens with bone marrow support.

C. Begg, B. Teicher, T. Shea, 1990, Seminars in oncology.

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

T. Shea, S. Come, J. Eder, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

J. Eder, A. Elias, L. Schnipper, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Dose Chemotherapy III Breast Cancer

C. Begg, B. Teicher, A. Elias, 1991 .

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

R. Bast, D. Schoenfeld, J. Eder, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow support.

D. Schoenfeld, T. Shea, J. Eder, 1988, Archives of dermatology.

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

B. Teicher, T. Shea, J. Eder, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors.

B. Teicher, T. Shea, J. Eder, 1988, Journal of the National Cancer Institute.

Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.

J. Eder, S. Graves, K. Antman, 1989, Clinical science.

Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.

R. Bast, J. Eder, L. Schnipper, 1986, Cancer research.

High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.

T. Shea, J. Eder, A. Elias, 1987, Cancer treatment reports.

High-Dose Chemotherapy in Breast Cancer

G. Hortobagyi, D. Heitjan, K. Antman, 1991 .

High-Dose Chemotherapy in Breast Cancer

B. Teicher, K. Antman, S. Schryber, 1991 .